Author details

Full Name

Kathryn R Taylor

Affiliation

ORCID

Career Start Year

2006

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36993539	Remote neuronal activity drives glioma infiltration via Sema4f.	bioRxiv	2023
37380778	Remote neuronal activity drives glioma progression through SEMA4F.	Nature	2023
36931244	Single substitution in H3.3G34 alters DNMT3A recruitment to cause progressive neurodegeneration.	Cell	2023
35043113	Mild respiratory SARS-CoV-2 infection can cause multi-lineage cellular dysregulation and myelin loss in the brain.	bioRxiv	2022
35768006	Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation.	Cell	2022
35756934	Case Report: Diagnosis of Petrous Apex IgG4-Related Disease by Middle Cranial Fossa Craniotomy and Temporal Bone Biopsy.	Frontiers in Neurology	2022
35931016	Invasive glioma cells: The malignant pioneers that follow the current.	Cell	2022
31098401	ALK2 inhibitors display beneficial effects in preclinical models of ACVR1 mutant diffuse intrinsic pontine glioma.	Commun Biol	2019
31534222	Electrical and synaptic integration of glioma into neural circuits.	Nature	2019
29160922	IGF1R signalling in testicular germ cell tumour cells impacts on cell survival and acquired cisplatin resistance.	Journal of Pathology	2018
29967352	Functional diversity and cooperativity between subclonal populations of pediatric glioblastoma and diffuse intrinsic pontine glioma cells.	Nat Med	2018
28966033	Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma.	Cancer Cell	2017
28434841	Transcriptional Dependencies in Diffuse Intrinsic Pontine Glioma.	Cancer Cell	2017
26399631	Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes.	Acta Neuropathol	2015
24705252	Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma.	Nat Genet	2014
25136070	ACVR1 mutations in DIPG: lessons learned from FOP.	Cancer Research	2014
24705254	Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations.	Nat Genet	2014
23539269	Histone H3.3. mutations drive pediatric glioblastoma through upregulation of MYCN.	Cancer Discov	2013
23918606	Dual blockade of the PI3K/AKT/mTOR (AZD8055) and RAS/MEK/ERK (AZD6244) pathways synergistically inhibits rhabdomyosarcoma cell growth in vitro and in vivo.	Clinical Cancer Research	2013
22065083	Antitumor activity of sustained N-myc reduction in rhabdomyosarcomas and transcriptional block by antigene therapy.	Clin Cancer Res	2012
16732718	Recent advances in targeting regulators of apoptosis in cancer cells for therapeutic gain.	Expert Opinion on Investigational Drugs	2006